Cargando…

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

Homologous recombination deficiency (HRD) is a defining characteristic in BRCA-deficient breast tumors caused by genetic or epigenetic alterations in key pathway genes. We investigated the frequency of BRCA1 promoter hypermethylation in 237 triple-negative breast cancers (TNBCs) from a population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glodzik, Dominik, Bosch, Ana, Hartman, Johan, Aine, Mattias, Vallon-Christersson, Johan, Reuterswärd, Christel, Karlsson, Anna, Mitra, Shamik, Niméus, Emma, Holm, Karolina, Häkkinen, Jari, Hegardt, Cecilia, Saal, Lao H., Larsson, Christer, Malmberg, Martin, Rydén, Lisa, Ehinger, Anna, Loman, Niklas, Kvist, Anders, Ehrencrona, Hans, Nik-Zainal, Serena, Borg, Åke, Staaf, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385112/ https://www.ncbi.nlm.nih.gov/pubmed/32719340 http://dx.doi.org/10.1038/s41467-020-17537-2

Ejemplares similares

Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study
por: Staaf, Johan, et al.
Publicado: (2019)

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
por: Larsson, Christer, et al.
Publicado: (2020)

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
por: Saal, Lao H, et al.
Publicado: (2015)

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
por: Brueffer, Christian, et al.
Publicado: (2020)

Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
por: Dahlgren, Malin, et al.
Publicado: (2021)

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative
por: Rydén, L., et al.
Publicado: (2018)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
por: Nacer, Deborah F., et al.
Publicado: (2023)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

Refinement of breast cancer molecular classification by miRNA expression profiles
por: Søkilde, Rolf, et al.
Publicado: (2019)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray
por: Vallon-Christersson, Johan, et al.
Publicado: (2007)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

Normalization of array-CGH data: influence of copy number imbalances
por: Staaf, Johan, et al.
Publicado: (2007)

Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
por: Arbajian, Elsa, et al.
Publicado: (2020)

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019)

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
por: Sigurjonsdottir, Gudbjörg, et al.
Publicado: (2023)

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
por: Bengtsson, Ylva, et al.
Publicado: (2023)

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
por: Veerla, Srinivas, et al.
Publicado: (2023)

BASE - 2nd generation software for microarray data management and analysis
por: Vallon-Christersson, Johan, et al.
Publicado: (2009)

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
por: Demircan, Kamil, et al.
Publicado: (2021)

Autoimmunity to selenoprotein P predicts breast cancer recurrence
por: Demircan, Kamil, et al.
Publicado: (2022)

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
por: Demircan, Kamil, et al.
Publicado: (2023)

Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios
por: Staaf, Johan, et al.
Publicado: (2008)

Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
por: Mosquim Junior, Sergio, et al.
Publicado: (2022)

Frequent miRNA-convergent fusion gene events in breast cancer
por: Persson, Helena, et al.
Publicado: (2017)

Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives
por: Nilsson, Martin P., et al.
Publicado: (2017)

Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
por: de Jong, Vincent M. T., et al.
Publicado: (2022)

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
por: Saal, Lao H, et al.
Publicado: (2002)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011)

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
por: Loman, Niklas, et al.
Publicado: (2003)

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4qomjc1qji7plntkjdaqblmt9n